Futura Medical Statistics
Total Valuation
Futura Medical has a market cap or net worth of 11.03 million. The enterprise value is 6.11 million.
| Market Cap | 11.03M |
| Enterprise Value | 6.11M |
Important Dates
The next estimated earnings date is Friday, December 12, 2025.
| Earnings Date | Dec 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 304.13M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.70% |
| Shares Change (QoQ) | -0.09% |
| Owned by Insiders (%) | 9.80% |
| Owned by Institutions (%) | 69.03% |
| Float | 243.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.02 |
| PB Ratio | 2.64 |
| P/TBV Ratio | 2.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 17.38 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.71 |
| EV / Sales | 0.58 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -10.12 |
Financial Position
The company has a current ratio of 2.23
| Current Ratio | 2.23 |
| Quick Ratio | 2.11 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -115.97% and return on invested capital (ROIC) is -72.54%.
| Return on Equity (ROE) | -115.97% |
| Return on Assets (ROA) | -52.66% |
| Return on Invested Capital (ROIC) | -72.54% |
| Return on Capital Employed (ROCE) | -185.87% |
| Revenue Per Employee | 775,702 |
| Profits Per Employee | -615,994 |
| Employee Count | 14 |
| Asset Turnover | 1.06 |
| Inventory Turnover | 166.31 |
Taxes
In the past 12 months, Futura Medical has paid 44,986 in taxes.
| Income Tax | 44,986 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.00% in the last 52 weeks. The beta is 0.58, so Futura Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | -90.00% |
| 50-Day Moving Average | 0.08 |
| 200-Day Moving Average | 0.14 |
| Relative Strength Index (RSI) | 51.24 |
| Average Volume (20 Days) | 11,231 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Futura Medical had revenue of 10.86 million and -8.62 million in losses. Loss per share was -0.03.
| Revenue | 10.86M |
| Gross Profit | 7.00M |
| Operating Income | -8.63M |
| Pretax Income | -8.58M |
| Net Income | -8.62M |
| EBITDA | -8.46M |
| EBIT | -8.63M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 5.05 million in cash and n/a in debt, giving a net cash position of 5.05 million.
| Cash & Cash Equivalents | 5.05M |
| Total Debt | n/a |
| Net Cash | 5.05M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 4.17M |
| Book Value Per Share | 0.01 |
| Working Capital | 3.54M |
Cash Flow
In the last 12 months, operating cash flow was 634,664 and capital expenditures -1.24 million, giving a free cash flow of -603,495.
| Operating Cash Flow | 634,664 |
| Capital Expenditures | -1.24M |
| Free Cash Flow | -603,495 |
| FCF Per Share | n/a |
Margins
Gross margin is 64.49%, with operating and profit margins of -79.48% and -79.41%.
| Gross Margin | 64.49% |
| Operating Margin | -79.48% |
| Pretax Margin | -79.00% |
| Profit Margin | -79.41% |
| EBITDA Margin | -77.91% |
| EBIT Margin | -79.48% |
| FCF Margin | n/a |
Dividends & Yields
Futura Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.70% |
| Shareholder Yield | -0.70% |
| Earnings Yield | -78.20% |
| FCF Yield | -5.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Futura Medical has an Altman Z-Score of -1.31 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.31 |
| Piotroski F-Score | 2 |